We are currently experiencing technical issues. We appreciate your patience as we investigate.
Morningstar
RecommendedGuide to Asset Flows Open Window IconGuide to Indexes for Fund Management Open Window IconInvestment Analysis Platform for Fund Managers Fund Insights

AXA Framlington Monthly Income R GBP Acc

Register to Unlock Ratings
Performance History30/11/2021
Growth of 1,000 (GBP) Advanced Graph
AXA Framlington Monthly Income R GBP Acc
Fund16.0-10.217.1-9.015.2
+/-Cat5.30.3-1.93.52.7
+/-B’mrk2.9-0.7-2.10.82.1
 
Category: UK Equity Income
Category Benchmark: FTSE AllSh TR GBP
Key Stats
NAV
06/12/2021		 GBX 720.60
Day Change 0.56%
Morningstar Category™ UK Equity Income
IA (formerly IMA) Sector UK Equity Income
ISIN GB0003490595
Fund Size (Mil)
31/10/2021		 GBP 265.72
Share Class Size (Mil)
03/12/2021		 GBP 46.44
Max Initial Charge 5.25%
Ongoing Charge
24/09/2021		  1.59%
Investment Objective: AXA Framlington Monthly Income R GBP Acc
The aim of this Fund is to provide a monthly income with potential for long-term growth of capital. The Manager intends to achieve a yield of distributable income in excess of 100% of the FTSE All Share yield at the Fund’s year end on a rolling 3 year basis, and in excess of 90% on an annual basis.The Fund invests primarily in shares of UK listed companies which the Manager believes will provide above-average income and capital growth. The Fund invests in companies of any size. The Fund also invests in bonds issued by companies or governments. The Manager selects shares based upon analysis of a company’s prospects for future growth in dividend payments, financial status, quality of its management, expected profitability and prospects for growth.
Returns
Trailing Returns (GBP)06/12/2021
YTD17.40
3 Years Annualised6.97
5 Years Annualised6.41
10 Years Annualised8.65
12 Month Yield 3.73
Management
Manager Name
Start Date
George Luckraft
24/03/2006
Simon Young
01/03/2021
Inception Date
08/10/1984
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
FTSE AllSh TR GBPFTSE AllSh TR GBP
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeYes
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA Framlington Monthly Income R GBP Acc31/10/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock87.680.0087.68
Bond0.000.000.00
Property0.000.000.00
Cash3.050.003.05
Other9.270.009.27
Top 5 Regions%
United Kingdom92.04
United States7.96
Canada0.00
Latin America0.00
Eurozone0.00
Top 5 Sectors%
Financial Services25.08
Industrials13.02
Healthcare11.11
Consumer Defensive10.85
Energy10.73
Top 5 HoldingsSector%
iEnergizer LtdTechnologyTechnology4.36
GlaxoSmithKline PLCHealthcareHealthcare3.83
Royal Dutch Shell PLC BEnergyEnergy3.67
AstraZeneca PLCHealthcareHealthcare3.42
Intermediate Capital Group PLCFinancial ServicesFinancial Services3.14
Increase Decrease New since last portfolio
AXA Framlington Monthly Income R GBP Acc

Related

Equity Research & Insights
5 Companies that have Restored Dividends
Dividend cuts and cancellations dominated the start of the year, but some companies have already started to reinstate their payouts as conditions impr...
Frozen pound thumbnail
James Gard
Fund Research & Insights
8 Income Funds That Yield 1% or Less
Income investors must do their homework before choosing a fund - Morningstar data reveals at least 38 funds with "Income" in their name yield less tha...
Magnifying glass thumbnail 2
Holly Black
Fund Research & Insights
5 Best and Worst-Performing Funds in 2019
Funds focused on China, the US and technology outperformed in the first quarter of 2019, while an absolute return offering was bottom of the pile
India china 1
David Brenchley
ISA Investing
What ISA Funds Are Millennials and Baby Boomers Buying?
There are similarities in the funds bought by both millennials and baby boomers. While the younger generation take more risk, those nearing retirement...
Young family
David Brenchley
Fund Rating News
Morningstar Fund Ratings: Weekly Round-up
ANALYST RATINGS: This week Morningstar analysts reveal downgrades for Carmignac and Schroders following fund manager changes
Iain Licenced Analyst Rating Medal Gold Silver Bronze
Morningstar Analysts
Equity Research & Insights
Value Investors Focus on Banks
Bank stocks are amongst the cheapest companies in the world, trading well below their true worth, and value fund managers continue to find opportuniti...
Canary Wharf banks HSBC Barclays
David Brenchley
Equity Research & Insights
Can Healthcare Stocks Continue their 2018 Rally?
Investors looking for defensive investments in an uncertain world may benefit from looking at healthcare stocks, which was the best-performing sector ...
Drugs pills pharma health 154306161 1
David Brenchley
Equity Research & Insights
Carmignac: Sell Amazon for Facebook
Could this be the end of the rally for high-multiple tech stocks like Amazon? Carmignac's David Older thinks it could pay to back Facebook instead
Facebook new
David Brenchley
Market Update
Carmignac: Prepare for a Stock Market Double Dip
The worst may be yet to come for US stocks, says French asset manager Carmignac. Historially, there are two slumps before a market rally
Stock market
David Brenchley
Fund Research & Insights
Edouard Carmignac Steps Back from Fund Management
Carmignac Patrimoine's veteran manager Edouard Carmignac has relinquished his portfolio management duties on the flagship fund. Analysts will review t...
Underreview,
Mara Dobrescu
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement       

The Morningstar Star Rating for Stocks is assigned based on an analyst's estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn't. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here

Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here

Select Your Site Edition To make sure the site is relevant to you, we need to know if you’re an individual investor or a financial professional.